RxDoctor Payments Data

Jassie McGovern, DPM

Foot & Ankle Surgery · Terre Haute, INNPI 1659878734

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Arthrex at 24.1% of the total. Reporting peaked in 2021 at $6,988 and has fallen 92.5% since, to $524 in 2025.

$14,629in general payments, 2019–2025

Across 227 payments — averaging $64.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Novus Surgical Solutions LLC$3K
  • Mid-atlantic Surgical Systems, LLC$2K
  • Stryker$1K
  • Orthofix Medical, Inc.$1K
  • Paragon 28, Inc.$932
  • plus $3K from 23 others

What the payments were for

  • Travel & lodging$3,97327%
  • Food & beverage$4,65632%
  • Education$6,00041%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,629 in reported general payments places this provider in the 80th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$71,792
Medicare patients
271
Services billed
883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole20$344
Gabapentin27$184
Meloxicam32$128
Oxycodone Hcl19$25

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Terre Haute

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →